- Home
- CIGI vs RVMD Comparison
CIGI vs RVMD Comparison
Compare CIGI & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIGI
- RVMD
- Stock Information
- Founded
- CIGI 1972
- RVMD 2014
- Country
- CIGI Canada
- RVMD United States
- Employees
- CIGI N/A
- RVMD N/A
- Industry
- CIGI
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CIGI
- RVMD Health Care
- Exchange
- CIGI Nasdaq
- RVMD Nasdaq
- Market Cap
- CIGI 6.1B
- RVMD 7.5B
- IPO Year
- CIGI N/A
- RVMD 2020
- Fundamental
- Price
- CIGI $133.48
- RVMD $37.87
- Analyst Decision
- CIGI Buy
- RVMD Strong Buy
- Analyst Count
- CIGI 6
- RVMD 12
- Target Price
- CIGI $160.33
- RVMD $68.67
- AVG Volume (30 Days)
- CIGI 123.8K
- RVMD 3.1M
- Earning Date
- CIGI 07-31-2025
- RVMD 08-06-2025
- Dividend Yield
- CIGI 0.22%
- RVMD N/A
- EPS Growth
- CIGI 38.82
- RVMD N/A
- EPS
- CIGI 2.86
- RVMD N/A
- Revenue
- CIGI $4,961,214,000.00
- RVMD N/A
- Revenue This Year
- CIGI $13.69
- RVMD N/A
- Revenue Next Year
- CIGI $6.68
- RVMD $241.39
- P/E Ratio
- CIGI $46.52
- RVMD N/A
- Revenue Growth
- CIGI 13.50
- RVMD N/A
- 52 Week Low
- CIGI $100.86
- RVMD $29.17
- 52 Week High
- CIGI $156.96
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- CIGI 59.15
- RVMD 44.16
- Support Level
- CIGI $129.25
- RVMD $36.65
- Resistance Level
- CIGI $133.54
- RVMD $38.18
- Average True Range (ATR)
- CIGI 2.99
- RVMD 1.53
- MACD
- CIGI -0.07
- RVMD -0.31
- Stochastic Oscillator
- CIGI 69.21
- RVMD 29.10
About CIGI Colliers International Group Inc. Subordinate Voting Shares
Colliers International Group Inc provides commercial real estate professional services and investment management to corporate and institutional clients across different countries around the world. Its operating segments are; Real Estate Services, Engineering, Investment Management, and Corporate. Maximum revenue for the company is generated from its Real Estate Services segment, which offers services like transaction and debt finance services, outsourcing in property management, valuation and advisory, loan servicing, property sales brokerage, and lease brokerage services, among others. Geographically, the company generates maximum revenue from the United States and the rest from Canada, Australia, the United Kingdom, Poland, China, India, and other regions.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.